KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Assets Average (2016 - 2025)

Historic Assets Average for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to $1.2 billion.

  • Fulgent Genetics' Assets Average fell 209.25% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 209.25%. This contributed to the annual value of $1.2 billion for FY2024, which is 633.59% down from last year.
  • As of Q3 2025, Fulgent Genetics' Assets Average stood at $1.2 billion, which was down 209.25% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Assets Average ranged from a high of $1.5 billion in Q2 2022 and a low of $849.8 million during Q1 2021
  • Over the past 5 years, Fulgent Genetics' median Assets Average value was $1.2 billion (recorded in 2024), while the average stood at $1.3 billion.
  • In the last 5 years, Fulgent Genetics' Assets Average surged by 100609.91% in 2021 and then crashed by 1077.19% in 2024.
  • Quarter analysis of 5 years shows Fulgent Genetics' Assets Average stood at $1.2 billion in 2021, then grew by 12.42% to $1.4 billion in 2022, then dropped by 7.1% to $1.3 billion in 2023, then decreased by 5.4% to $1.2 billion in 2024, then dropped by 1.6% to $1.2 billion in 2025.
  • Its Assets Average was $1.2 billion in Q3 2025, compared to $1.2 billion in Q2 2025 and $1.2 billion in Q1 2025.